148 related articles for article (PubMed ID: 19124741)
1. PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination.
Finnefrock AC; Tang A; Li F; Freed DC; Feng M; Cox KS; Sykes KJ; Guare JP; Miller MD; Olsen DB; Hazuda DJ; Shiver JW; Casimiro DR; Fu TM
J Immunol; 2009 Jan; 182(2):980-7. PubMed ID: 19124741
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.
Velu V; Kannanganat S; Ibegbu C; Chennareddi L; Villinger F; Freeman GJ; Ahmed R; Amara RR
J Virol; 2007 Jun; 81(11):5819-28. PubMed ID: 17376899
[TBL] [Abstract][Full Text] [Related]
3. Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.
Wu C; He Y; Zhao J; Luo K; Wen Z; Zhang Y; Li M; Cui Y; Liu Z; Wang C; Han Z; Li G; Feng F; Li P; Chen L; Sun C
J Virol; 2022 Feb; 96(3):e0178521. PubMed ID: 34818070
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
5. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
6. Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys.
Pan E; Feng F; Li P; Yang Q; Ma X; Wu C; Zhao J; Yan H; Chen R; Chen L; Sun C
Front Immunol; 2018; 9():2415. PubMed ID: 30405615
[TBL] [Abstract][Full Text] [Related]
7. Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression.
Xu H; Wang X; Pahar B; Moroney-Rasmussen T; Alvarez X; Lackner AA; Veazey RS
J Immunol; 2010 Dec; 185(12):7340-8. PubMed ID: 21059890
[TBL] [Abstract][Full Text] [Related]
8. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
9. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
11. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.
McDermott AB; O'Connor DH; Fuenger S; Piaskowski S; Martin S; Loffredo J; Reynolds M; Reed J; Furlott J; Jacoby T; Riek C; Dodds E; Krebs K; Davies ME; Schleif WA; Casimiro DR; Shiver JW; Watkins DI
J Virol; 2005 Dec; 79(24):15556-66. PubMed ID: 16306626
[TBL] [Abstract][Full Text] [Related]
13. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
[TBL] [Abstract][Full Text] [Related]
14. Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: a proof of concept study in macaques.
Koopman G; Beenhakker N; Hofman S; Walther-Jallow L; Mäkitalo B; Mooij P; Anderson J; Verschoor E; Bogers WM; Heeney JL; Spetz AL
Vaccine; 2012 Mar; 30(15):2523-34. PubMed ID: 22314133
[TBL] [Abstract][Full Text] [Related]
15. Enhancing SIV-specific immunity in vivo by PD-1 blockade.
Velu V; Titanji K; Zhu B; Husain S; Pladevega A; Lai L; Vanderford TH; Chennareddi L; Silvestri G; Freeman GJ; Ahmed R; Amara RR
Nature; 2009 Mar; 458(7235):206-10. PubMed ID: 19078956
[TBL] [Abstract][Full Text] [Related]
16. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
17. Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).
Gill AL; Green SA; Abdullah S; Le Saout C; Pittaluga S; Chen H; Turnier R; Lifson J; Godin S; Qin J; Sneller MC; Cuillerot JM; Sabzevari H; Lane HC; Catalfamo M
AIDS; 2016 Oct; 30(16):2487-2493. PubMed ID: 27490642
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression.
Smith SM; Holland B; Russo C; Dailey PJ; Marx PA; Connor RI
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1691-701. PubMed ID: 10606092
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the relative therapeutic effects of vaccines on virus load and immune responses in small groups at several time points: efficacy of mucosal and subcutaneous polypeptide vaccines in rhesus macaques exposed to SHIV.
Kuznetsov VA; Stepanov VS; Berzofsky JA; Belyakov IM
J Clin Virol; 2004 Dec; 31 Suppl 1():S69-82. PubMed ID: 15567097
[TBL] [Abstract][Full Text] [Related]
20. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
